Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02410902 : A Trial of CM-AT in Children With Autism With All Levels of FCT
PhasePhase 3
AgesMin: 3 Years Max: 8 Years
Eligibility
Inclusion Criteria:

- Meets the current Diagnostic and Statistical Manual with Mental Disorders (DSM-IV-TR)
for Autism (Autistic Disorder), screened by SCQ and confirmed by ADI-R;

Exclusion Criteria:

- Patient weighing < 13kg (28.6 lbs)

- Previous allergy to porcine (pork) products

- Previous history of severe head trauma or stroke, loss of consciousness, seizure (or
need for seizure medication either present or past) within one year of entering study
or uncontrolled systemic disease

- Diagnosis of: HIV, cerebral palsy, endocrine disorder, pancreatic disease, muscular
dystrophy, known genetic disorder, blood dyscrasia, ongoing GI disease

- Evidence of severe, moderate or uncontrolled systemic disease; and/or any co-morbid
condition which in the Investigator's or Medical Director's opinion makes it
undesirable for the subject to participate in the study or jeopardizes compliance
with the protocol;

- Within 30 days of starting the study, certain supplementation, chelation or dietary
restriction (a 30 day washout period would be required for inclusion);

- Ongoing dietary restriction for allergy or other reasons except nut allergies
(lactose-free allowable);

- Use of of any stimulant medication must be discontinued 5 days prior to entering the
study.

- Subject must have a stable dose of SSRI's for at least 30 days.

- Inability to ingest study drug and/or follow prescribed dosing schedule
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02410902      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740